One vision —
a cancer-free future.
Unlike surgery, chemotherapy and radiation, cell and gene therapies harness the power of your immune system to destroy cancer cells without harming healthy tissue. We fund the research that will make this vision a reality.
Oncolytic virus therapy: How viruses can kill tumor cells
ACGT has funded research programs using oncolytic virus therapy for solid tumors like glioblastoma, breast cancer and more.
ACGT's impact on display during annual SITC meeting
ACGT Research Fellows and Scientific Advisory Council members were part of panel discussions and presentations about the progress in cell and gene therapy.
CAR T-cell study leads to near-100% remission rate for children with leukemia
St. Jude Children's Research Hospital collaborated with a hospital in China on a study of children with acute lymphoblastic leukemia.
Relationship between cell and gene therapy and the blood-brain barrier and
The blood-brain barrier can impede immune cells and treatment from reaching brain tumors, but there are ways around this wall.
Our direct impact on eradicating all cancer.
Collaborating with partners and funding research fellows, we are transforming cancer treatments today while bringing the world closer to a cure for all cancers tomorrow.
31.5
million dollars awarded to groundbreaking research.
61
research fellows supported.
36
of the top medical institutions funded.
Join forces with the world’s leading researchers to finally identify cures.
Cell and gene therapies harness the power of a patient’s own immune system to destroy cancer cells without harming healthy tissue.
Matthias Stephan, MD, PhD
Fred Hutchinson Cancer Research Center
Advancing pre-clinical strategies that combine principles of bioengineering with gene therapy to improve the effectiveness of therapeutic cancer vaccines.
Stephen Gottschalk, MD
St. Jude Children’s Research Hospital
Fortifying a patient’s immune system to attack and destroy sarcomas along with the blood vessels that support their growth.
Daniel J. Powell, PhD
University of Pennsylvania
Using genetic engineering to engage a patient’s existing immune system and enable it to recognize and destroy ovarian cancer.
Brian Brown, PhD
Icahn School of Medicine at Mount Sinai
Working to harness the power of gene therapy to equip a patient’s own T cells to kill immune-suppressing cells.
Matthias Stephan, MD, PhD
Fred Hutchinson Cancer Research Center
Advancing pre-clinical strategies that combine principles of bioengineering with gene therapy to improve the effectiveness of therapeutic cancer vaccines.
Stephen Gottschalk, MD
St. Jude Children’s Research Hospital
Fortifying a patient’s immune system to attack and destroy sarcomas along with the blood vessels that support their growth.
Daniel J. Powell, PhD
University of Pennsylvania
Using genetic engineering to engage a patient’s existing immune system and enable it to recognize and destroy ovarian cancer.
Brian Brown, PhD
Icahn School of Medicine at Mount Sinai
Working to harness the power of gene therapy to equip a patient’s own T cells to kill immune-suppressing cells.
Stay up-to-date with us and get involved.
Oct 05, 2022
100% of your donation will advance research to cure all cancers.
Your donation will help develop radical new cell and gene therapies that leverage the body’s own biology and immune system to control and ultimately eradicate cancer. 100% of donations directly support scientists working on breakthrough cancer cell and gene therapy research.
Donate Today